Providers
All 18 in CA
AZURE HOSPICE CARE INC
NPI 1205355682, organization, Garden Grove, CA, Hospice Care, Community Based
Evidence tier
No indicators
No detector reached this NPI and it appears on none of the loaded lists.
Public list actions
Medicare revocation effective June 29, 2024, barred from re-enrolling until June 28, 2034
424.535(a)(19) affiliation that poses an undue risk, Part A Provider - Hospice, CA
National provider registry
From the CMS NPPES Registry, refreshed daily.
| Name | AZURE HOSPICE CARE INC |
| Type | Organization |
| Status | Active |
| NPI issued | September 16, 2017, last updated July 21, 2022 |
| Practice location | 12391 LEWIS ST STE 202, Garden Grove, CA 92840-4668, 714-591-5005 |
| Authorized official | Lynn Galbraith (Ceo) |
| Specialties | Hospice Care, Community Based (251G00000X, primary) |
In this area
18 providers in Garden Grove, CA carry an indicator in the public record, with $5.1M at stake between them. The most common is part of a provider network, on 10 of them, followed by more hours than a day holds on 6. 1 is tier 1: documented action, then payment.
| tier | provider | at stake | why |
|---|---|---|---|
| 1 | PAUL JOHNSON Garden Grove, CA, ranked 412 | $514 |
|
| 3 | SINCERE HOSPICE AND PALLIATIVE CARE INC. Garden Grove, CA, ranked 2222 | $0 |
|
| 3 | WARM CARE HOSPICE AND PALLIATIVE CARE Garden Grove, CA, ranked 2518 | $0 |
|
| 3 | VMKJ HEALTHCARE LLC Garden Grove, CA, ranked 2664 | $0 |
|
| 3 | FOCUS HOME HEALTH, INC. Garden Grove, CA, ranked 3010 | $0 |
|
| 3 | ADVOCARE HOSPICE, INC Garden Grove, CA, ranked 3302 | $0 |
|
| 3 | FIRST TOUCH HOME HEALTH CARE INC. Garden Grove, CA, ranked 3535 | $0 |
|
| 3 | COMMITTED HOSPICE CARE INC. Garden Grove, CA, ranked 3549 | $0 |
|
Recent enforcement in CA
All releasesDepartment of Justice and HHS-OIG releases for this state, newest first. Each opens in a new tab.
DOJPleaded guiltyAug 27, 2026
Anaheim Woman Pleads Guilty to Submitting More Than $2.2 Million in Fraudulent Hospice Care Claims to Medicare
Galbraith submitted approximately $2,266,694 in claims to Medicare for hospice services for beneficiaries who did not have a terminal illness with a life expectancy of six months or less, and Medicare paid her company approximately $2,140,606.
DOJCivil settlementAug 26, 2026
DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests
DermTech Inc. submitted claims to Medicare for skin cancer tests conducted with an unvalidated positive control range and for tests lacking sufficient patient RNA, and did not retract results or adequately refund Medicare.
DOJCivil settlementAug 26, 2026
DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests
DermTech Inc. billed Medicare for skin cancer tests conducted using an unvalidated positive control range and for tests with insufficient patient RNA, and did not retract the results or adequately refund Medicare.
DOJCivil settlementAug 24, 2026
Medicare Advantage Provider Monogram Health Agrees to Pay $2.4 Million to Settle False Claims Act Lawsuit
Monogram knowingly submitted diagnosis codes in four HCCs that were not clinically accurate, not supported by medical record documentation, and/or did not require or affect patient care, inflating Medicare Advantage beneficiaries' risk scores and causing CMS to make higher capitated payments to Medicare Advantage Organizations.
DOJCivil settlementAug 24, 2026
Medicare Advantage Provider Monogram Health Agrees to Pay $2.4M to Settle False Claims Act Suit
Monogram Health knowingly submitted diagnosis codes within four HCCs that were not clinically accurate, not supported by medical record documentation, and/or did not require or affect patient care, inflating Medicare Advantage beneficiaries' risk scores and causing CMS to make higher capitated payments to MAOs.
Referral packet
The packet is a draft for a reviewer. It reads every public record behind this case, states what the records show with a citation for each finding, names the regulation each finding relates to, and lists the ordinary explanations to rule out first. It never asserts intent.